Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Management 98

Legacy MEDSearch

OCTOBER 16, 2023

” Proprio’s Paradigm secured FDA 510(k) clearance and significant additional funding earlier this year and is being deployed into select leading hospitals across the US and abroad. For more information, visit www.propriovision.com/. AG, Intel, HTC, and Alan Frazier, founder of Frazier Healthcare Partners.

Recruitment 52

Recruitment Medical Healthcare Healthcare 52

Clarify Health

OCTOBER 26, 2021

Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. To advance equity in clinical research, the U.S. In fact, 73% were White, 14% were Asian, 6% were Hispanic, and 5% were African American.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

World of DTC Marketing

FEBRUARY 4, 2021

I am reminded of a business colleague who left a company in the midwest after being recruited heavily by Amgen. prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4 She moved to the area and was excited at, what she thought, were new and exciting opportunities. Annual U.S.

Pharma 180

Pharma Food and Drug Administration Side effects Safety 180

Legacy MEDSearch

OCTOBER 25, 2023

The company’s award-winning flagship wearable, Nerivio ® , is an FDA-cleared and CE-marked prescription device for complete care of migraine – acute and/or preventive treatment of chronic or episodic migraine with or without aura in people 12 years or older.

Side effects 52

Side effects Recruitment Networking Management 52

pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

Food and Drug Administration 104

Food and Drug Administration Prescription Media Patients 104

MedCity News

JUNE 12, 2023

Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations. This strategy eliminates the per-unit sticker price, but at the cost of losing the FDA credibility. The result was more diverse and inclusive data.

Food and Drug Administration 92

Food and Drug Administration Prescription Government FDA 92

Clarivate

NOVEMBER 23, 2021

For example, in the United States, the FDA’s view on data is evolving, especially as it concerns upstream usage for clinical and regulatory use cases. One of them is site intelligence, but we have a patient recruitment team that works hand on hand—we lock arms and we have another team that focuses on that trial diversity.

Patients 52

Patients Recruitment Management Healthcare 52

PM360

SEPTEMBER 15, 2022

People get tired of feeling that they are their sickness; they’re tired of carrying the baggage of being a “patient,” and they want to be seen and treated like the person they are, not the prescription they take. From a recruitment and retention perspective, DEI can be embedded into outreach and engagement campaigns.

Patients 98

Patients Healthcare Healthcare Marketing 98

Clarify Health

DECEMBER 13, 2022

We brought together three leaders who are working to change these statistics by bringing recruitment to the patient and leveraging real-world evidence (RWE) to innovate trial design and accelerate recruitment. With real-world data, you can see that pattern clearly and more precisely recruit the right patients into the trial.”.

Recruitment 52

Recruitment Retail Patients FDA 52

Clarify Health

DECEMBER 13, 2022

We brought together three leaders who are working to change these statistics by bringing recruitment to the patient and leveraging real-world evidence (RWE) to innovate trial design and accelerate recruitment. With real-world data, you can see that pattern clearly and more precisely recruit the right patients into the trial.”

Recruitment 52

Recruitment Retail Patients FDA 52

Cadensee

JULY 20, 2021

So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology. But you excluded all those patients and then you don't understand why you can't recruit. They can help you recruit through those communities.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52